Preliminary program

June 16th

Session 1 - Metabolism and metabolomics in cancer and disease

Erik Knutsen - Opening remarks

Dentist Olaf Aase and wife memorial lecture:

Daniel Tennant - Amino acid metabolism and the tumour microenvironment – essential lessons from studying non-essential nutrients

Katja Benedikte Prestø Elgstøen - Global metabolomics; revealing a detailed metabolic landscape

Veronika Pettersen - Tracking Metabolic Output of the Gut Microbiome in Children with and without Cancer Diagnosis

Torbjørn Myhre - How Do We Make Sense of Untargeted Metabolomics Data?

Jack-Ansgar Bruun - PRiME Proteomics and Metabolomics Core Facility

Ole Kristian Greiner Tollersrud - The role of lysosomal metabolism in inflammation

Eelke Snoeren - The effects of junk food consumption on brain and behavior

Nelsy Taboko-Foncha - OPA1 overexpression ameliorates calcium-induced mitochondrial swelling and prevents death in cardio-myoblast

Session 2 - Combining basic and translational research

Rolv-Ole Lindsetmo - Comprehensive Cancer Centre (CCC) at UNN- How will research be implemnted in the center?

Morten Bøhmer Strøm - Clinical Academic Groups (CAG) - a model and a tool for professional collaboration between clinicians and researchers in healthcare institutions

Erik Sveberg Dietrichs - Translational research to reduce risk of cardiovascular events and improve safety of treatment for psychiatric disorders

Panel Debate - How to include basic research in clinical trials at UNN?

Piyapan Suwattananuruk - PET Imaging of the C-X-C Chemokine Receptor Type 4 in a Glioblastoma Animal Model using a Novel Ga-68-Labeled Tetrahydroquinoline radiotracer

Maria Therese Ahlen - Prophylactic treatment to avoid platelet alloimmunization in pregnant women: can we design antibody variants for a more favorable risk profile during pregnancy?

Synnøve Magnussen - Combining molecular analysis with a clinical case

Eduarda Guerreiro - Surface of extracellular vesicles from activated platelets are decorated with coagulation-associated proteins

June 17th

Session 3 - From 2D to 3D, organoid, and organ-on-chip

Stefan Krauss - TBA

Harry Dawson - Generating real life like preclinical data with 3D organs on well: case studies on breast cancer and adipose tissue organoids, is biological complexity needed?

Marko Sankala (Merck) - 3D culture and Organoids

Zhe Xing and Jiazheng Cai - Advancing Cell Modeling: The Shift from 2D to 3D

Kajangi Gnanachandran - Studying the adverse effects of polypharmacy on liver sinusoidal endothelial cells (LSEC) in mouse liver-derived in vitro models: advancing from 2D to 3D systems

Bartlomiej Zapotoczny - Engineering the Liver Niche In Vitro: The Role of Soft Substrates in Culturing LSEC

Åsa Birna Birgisdottir - Exploiting cardiomyocytes derived from human induced pluripotent stem cells and engineered heart tissue for studying cellular mechanism in the human heart.

Hege Lynum Pedersen - From 2D to 3D culturing of renal proximal tubule epithelial cells (RPTEC)

Session 4 - Sustainable research and clinical practice

Ernst Ahlberg - AI decision making in pharmaceutical research

Margit Hågå - TBA

Anila Nauni (Research Council of Norway) - RCNs funding for promoting sustainability - tools and portfolio – examples from clinical research

Huw Haugland-Grange - FAIR and "as open as possible": what does this mean in practice for your research data?

Espen Åberg (Elixir Norway) - The Norwegian Microbial Data Platform: A Hub for FAIR Pathogen Data Sharing

Susannah von Hofsten - Embryonic development and EMT state are decisive for expression of the proteoglycan core proteins in human tissue

Erik Knutsen - Closing remarks




Attachments: